Back to video list Back to Home Is there CGRP pathway monoclonal antibody off target effects? You may also like Migraine Congress highlights Article Insights into neural pathways in migraine Schizophrenia Article Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help? Schizophrenia Congress highlights Article Improving treatment adherence in patients with early-phase schizophrenia Alzheimer's Disease Article ASAD 2024 Highlights – Immunotherapies in Dementia 2024
